Allowed Publications
Slot System
Featured Buckets
Featured Buckets Admin

Does NSAID Use Affect FOB Results?

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Does NSAID Use Affect FOB Results?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(4)
Publications
Page Number
24
Legacy Keywords
NSAID, nonsteroidal anti-inflammatory drugs, fecal occult blood test, FOB test, colonoscopy, aspirinNSAID, nonsteroidal anti-inflammatory drugs, fecal occult blood test, FOB test, colonoscopy, aspirin
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(4)
Issue
Federal Practitioner - 22(4)
Page Number
24
Page Number
24
Publications
Publications
Article Type
Display Headline
Does NSAID Use Affect FOB Results?
Display Headline
Does NSAID Use Affect FOB Results?
Legacy Keywords
NSAID, nonsteroidal anti-inflammatory drugs, fecal occult blood test, FOB test, colonoscopy, aspirinNSAID, nonsteroidal anti-inflammatory drugs, fecal occult blood test, FOB test, colonoscopy, aspirin
Legacy Keywords
NSAID, nonsteroidal anti-inflammatory drugs, fecal occult blood test, FOB test, colonoscopy, aspirinNSAID, nonsteroidal anti-inflammatory drugs, fecal occult blood test, FOB test, colonoscopy, aspirin
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Adrenal Insufficiency and Vasopressor-Resistant Hypotension in Critical Illness

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Adrenal Insufficiency and Vasopressor-Resistant Hypotension in Critical Illness

Article PDF
Author and Disclosure Information

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Albert Einstein College of Medicine and Quadrant HealthCom Inc. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Albert Einstein College of Medicine designates this educational activity for a maximum of 1.0 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he or she actually spent in the activity.

Peter A. Baylor, MD

Dr. Baylor is the associate chief of the pulmonary section at the VA Central California Health Care System, Fresno and an assistant clinical professor of medicine at the Fresno Medical Education Program of the University of California, San Fransisco.

Issue
Federal Practitioner - 22(3)
Publications
Page Number
60
Legacy Keywords
adrenal insufficiency, kidney disease, critical illness, vasopressor-resistant hypotension, hypotensionadrenal insufficiency, kidney disease, critical illness, vasopressor-resistant hypotension, hypotension
Sections
Author and Disclosure Information

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Albert Einstein College of Medicine and Quadrant HealthCom Inc. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Albert Einstein College of Medicine designates this educational activity for a maximum of 1.0 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he or she actually spent in the activity.

Peter A. Baylor, MD

Dr. Baylor is the associate chief of the pulmonary section at the VA Central California Health Care System, Fresno and an assistant clinical professor of medicine at the Fresno Medical Education Program of the University of California, San Fransisco.

Author and Disclosure Information

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Albert Einstein College of Medicine and Quadrant HealthCom Inc. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Albert Einstein College of Medicine designates this educational activity for a maximum of 1.0 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he or she actually spent in the activity.

Peter A. Baylor, MD

Dr. Baylor is the associate chief of the pulmonary section at the VA Central California Health Care System, Fresno and an assistant clinical professor of medicine at the Fresno Medical Education Program of the University of California, San Fransisco.

Article PDF
Article PDF

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
60
Page Number
60
Publications
Publications
Article Type
Display Headline
Adrenal Insufficiency and Vasopressor-Resistant Hypotension in Critical Illness
Display Headline
Adrenal Insufficiency and Vasopressor-Resistant Hypotension in Critical Illness
Legacy Keywords
adrenal insufficiency, kidney disease, critical illness, vasopressor-resistant hypotension, hypotensionadrenal insufficiency, kidney disease, critical illness, vasopressor-resistant hypotension, hypotension
Legacy Keywords
adrenal insufficiency, kidney disease, critical illness, vasopressor-resistant hypotension, hypotensionadrenal insufficiency, kidney disease, critical illness, vasopressor-resistant hypotension, hypotension
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

New Warning for Atomoxetine

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
New Warning for Atomoxetine

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(3)
Publications
Topics
Page Number
48
Legacy Keywords
atomoxetine hydrochloride, liver injury, adverse drug effects, ADHD, attention deficit hyperactivity disorderatomoxetine hydrochloride, liver injury, adverse drug effects, ADHD, attention deficit hyperactivity disorder
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
48
Page Number
48
Publications
Publications
Topics
Article Type
Display Headline
New Warning for Atomoxetine
Display Headline
New Warning for Atomoxetine
Legacy Keywords
atomoxetine hydrochloride, liver injury, adverse drug effects, ADHD, attention deficit hyperactivity disorderatomoxetine hydrochloride, liver injury, adverse drug effects, ADHD, attention deficit hyperactivity disorder
Legacy Keywords
atomoxetine hydrochloride, liver injury, adverse drug effects, ADHD, attention deficit hyperactivity disorderatomoxetine hydrochloride, liver injury, adverse drug effects, ADHD, attention deficit hyperactivity disorder
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Effects of Statins in Type 2 Diabetes

Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
Effects of Statins in Type 2 Diabetes

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(3)
Publications
Topics
Page Number
48
Legacy Keywords
statins, diabetes, type 2 diabetes, cardiovasular diseasestatins, diabetes, type 2 diabetes, cardiovasular disease
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
48
Page Number
48
Publications
Publications
Topics
Article Type
Display Headline
Effects of Statins in Type 2 Diabetes
Display Headline
Effects of Statins in Type 2 Diabetes
Legacy Keywords
statins, diabetes, type 2 diabetes, cardiovasular diseasestatins, diabetes, type 2 diabetes, cardiovasular disease
Legacy Keywords
statins, diabetes, type 2 diabetes, cardiovasular diseasestatins, diabetes, type 2 diabetes, cardiovasular disease
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

AD and Anticholinergics Don't Mix

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
AD and Anticholinergics Don't Mix

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(3)
Publications
Page Number
47
Legacy Keywords
AD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementiaAD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementia
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
47
Page Number
47
Publications
Publications
Article Type
Display Headline
AD and Anticholinergics Don't Mix
Display Headline
AD and Anticholinergics Don't Mix
Legacy Keywords
AD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementiaAD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementia
Legacy Keywords
AD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementiaAD, Alzheimer's disease, adverse drug effects, neurology, anticholinergics, dementia
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Epilepsy Drugs and Fracture Risk

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Epilepsy Drugs and Fracture Risk

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(3)
Publications
Page Number
47
Legacy Keywords
epilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone lossepilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone loss
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
47
Page Number
47
Publications
Publications
Article Type
Display Headline
Epilepsy Drugs and Fracture Risk
Display Headline
Epilepsy Drugs and Fracture Risk
Legacy Keywords
epilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone lossepilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone loss
Legacy Keywords
epilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone lossepilepsy, fracture risk, adverse drug effects, interactions, drugs, treatment, bone loss
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Osteonecrosis and HAART

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Osteonecrosis and HAART

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(3)
Publications
Topics
Page Number
47
Legacy Keywords
HAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVNHAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVN
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(3)
Issue
Federal Practitioner - 22(3)
Page Number
47
Page Number
47
Publications
Publications
Topics
Article Type
Display Headline
Osteonecrosis and HAART
Display Headline
Osteonecrosis and HAART
Legacy Keywords
HAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVNHAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVN
Legacy Keywords
HAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVNHAART, highly active antiretroviral therapy, osteonecrosis, avascular necrosis of bone, AVN
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

DHEA to Treat Middle-Age Spread?

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
DHEA to Treat Middle-Age Spread?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
Page Number
70
Legacy Keywords
DHEA, dehydroepiandrosterone, obesityDHEA, dehydroepiandrosterone, obesity
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
70
Page Number
70
Publications
Publications
Article Type
Display Headline
DHEA to Treat Middle-Age Spread?
Display Headline
DHEA to Treat Middle-Age Spread?
Legacy Keywords
DHEA, dehydroepiandrosterone, obesityDHEA, dehydroepiandrosterone, obesity
Legacy Keywords
DHEA, dehydroepiandrosterone, obesityDHEA, dehydroepiandrosterone, obesity
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Rosiglitazone to Prevent Restenosis

Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
Rosiglitazone to Prevent Restenosis

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
Topics
Page Number
63
Legacy Keywords
rosiglitazone, restenosis, cardiovascular disease, diabetesrosiglitazone, restenosis, cardiovascular disease, diabetes
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
63
Page Number
63
Publications
Publications
Topics
Article Type
Display Headline
Rosiglitazone to Prevent Restenosis
Display Headline
Rosiglitazone to Prevent Restenosis
Legacy Keywords
rosiglitazone, restenosis, cardiovascular disease, diabetesrosiglitazone, restenosis, cardiovascular disease, diabetes
Legacy Keywords
rosiglitazone, restenosis, cardiovascular disease, diabetesrosiglitazone, restenosis, cardiovascular disease, diabetes
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Lisinopril and Tizanidine: Potential for Trouble

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Lisinopril and Tizanidine: Potential for Trouble

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(2)
Publications
Page Number
63
Legacy Keywords
lisinopril, tizanidine, hypertension, adverse drug effects, interactionslisinopril, tizanidine, hypertension, adverse drug effects, interactions
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(2)
Issue
Federal Practitioner - 22(2)
Page Number
63
Page Number
63
Publications
Publications
Article Type
Display Headline
Lisinopril and Tizanidine: Potential for Trouble
Display Headline
Lisinopril and Tizanidine: Potential for Trouble
Legacy Keywords
lisinopril, tizanidine, hypertension, adverse drug effects, interactionslisinopril, tizanidine, hypertension, adverse drug effects, interactions
Legacy Keywords
lisinopril, tizanidine, hypertension, adverse drug effects, interactionslisinopril, tizanidine, hypertension, adverse drug effects, interactions
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media